Dabigatran Etexilate (110 mg) Capsule | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Dabigatran Etexilate (110 mg) Capsule
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Capsule
Class: Direct Oral Anticoagulant — Direct Thrombin Inhibitor
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Dabigatran Etexilate (110 mg) Capsule Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Dabigatran Etexilate (110 mg) Capsule brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Dabigatran Etexilate (110 mg) Capsule is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Dabigatran Etexilate (110 mg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Stroke prevention in non-valvular AF (age ≥80 or higher bleeding risk)
- Secondary prevention after DVT/PE
- Hip/knee replacement VTE prophylaxis
Mechanism of Action
Dabigatran is a direct, reversible thrombin (factor IIa) inhibitor. By blocking thrombin, it prevents fibrin formation and platelet activation — without requiring antithrombin (unlike heparin) or affecting vitamin K-dependent factors (unlike warfarin).
Dosage & Administration
- Adults: 110 mg twice daily for AF stroke prevention in eligible patients.
- Adjust in renal impairment.
Side Effects
- Bleeding (epistaxis, GI), dyspepsia.
- Major bleeding less common than warfarin.
Contraindications
- Active bleeding.
- Severe renal impairment (CrCl <30).
- Mechanical heart valves.
- Active hepatic disease.
- Pregnancy.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Dabigatran Etexilate (110 mg) Capsule
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 1 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Dabigatran Etexilate (110 mg) Capsule — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Dabigatran Etexilate (110 mg) Capsule, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Dabigatran Etexilate (110 mg) Capsule?
Trumac Healthcare is a WHO-GMP certified manufacturer of Dabigatran Etexilate (110 mg) Capsule in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Dabigatran Etexilate (110 mg) Capsule available for PCD pharma franchise on monopoly basis?
Yes. We offer Dabigatran Etexilate (110 mg) Capsule for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Dabigatran Etexilate (110 mg) Capsule?
Available pack sizes include: 10 x 1 x 10 (Alu Alu).
What is the MRP / trade price for Dabigatran Etexilate (110 mg) Capsule?
MRPs range from ₹3562 to ₹3562 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Dabigatran Etexilate (110 mg) Capsule?